CopyFind
PROLOPA CAP 50-12.5
Prescription 🇨🇦 Canada

PROLOPA CAP 50-12.5

Analogs of PROLOPA CAP 50-12.5

Find cheaper analogs and generic equivalents for PROLOPA CAP 50-12.5.

Ingredients

Active Ingredient: levodopa, benserazide. product type: oral capsule medication. administration: must be used strictly under the guidance and supervision of a qualified healthcare professional. dosage and frequency are determined based on the patient's specif


Product Overview

About PROLOPA CAP 50-12.5

PROLOPA CAP 50-12.5 is a prescription medication designed to treat Parkinson's disease and related symptoms. It contains a combination of BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE) and LEVODOPA, which work together to improve muscle control and reduce the risk of complications associated with the disease.

Key Benefits & Uses

  • Relieves symptoms of Parkinson's disease, such as tremors, stiffness, and slowed movement.
  • Improves muscle control and coordination.
  • Helps to reduce the risk of complications associated with Parkinson's disease, such as falls and injuries.

Active Ingredient & Action

The active ingredients in PROLOPA CAP 50-12.5, BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE) and LEVODOPA, work together to increase the levels of dopamine in the brain. Dopamine is a neurotransmitter that plays a crucial role in regulating movement and muscle control. By increasing dopamine levels, PROLOPA CAP 50-12.5 helps to improve muscle control and reduce the risk of complications associated with Parkinson's disease.

Important Notes

Before taking PROLOPA CAP 50-12.5, it is essential to consult with a healthcare professional to discuss the potential risks and benefits. Common side effects may include nausea, vomiting, and dizziness. It is also essential to follow the recommended dosage and usage instructions carefully to minimize the risk of adverse reactions.

Find in Pharmacies

Compare local prices and distance for PROLOPA CAP 50-12.5.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.